DHR · Danaher Corp /De/ - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.95B | - | $6.05B | $5.94B | $5.74B | - | $5.80B | $5.74B | $5.80B | - |
| Cost of Revenue | $2.36B | - | $2.53B | $2.41B | $2.23B | - | $2.40B | $2.31B | $2.31B | - |
| Gross Profit | $3.59B | - | $3.52B | $3.52B | $3.51B | - | $3.40B | $3.43B | $3.49B | - |
| R&D | $387.00M | - | $378.00M | $403.00M | $379.00M | - | $383.00M | $391.00M | $368.00M | - |
| SG&A | $1.86B | - | $1.99B | $2.36B | $1.86B | - | $2.06B | $1.87B | $1.81B | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $193.00M | - | $177.00M | $178.00M | $181.00M | - | - | - | $179.00M | - |
| Operating Income | $1.34B | - | $1.15B | $760.00M | $1.27B | - | $958.00M | $1.17B | $1.31B | - |
| Interest Expense | $63.00M | - | $67.00M | $71.00M | $65.00M | - | $87.00M | $65.00M | $65.00M | - |
| Income Tax | $206.00M | - | $168.00M | $100.00M | $175.00M | - | $159.00M | $176.00M | $183.00M | - |
| Net Income | $1.03B | - | $908.00M | $555.00M | $954.00M | - | $818.00M | $907.00M | $1.09B | - |
| EPS - Basic | $1.45 | - | $1.28 | $0.77 | $1.33 | - | $1.13 | $1.23 | $1.47 | - |
| EPS - Diluted | $1.45 | - | $1.27 | $0.77 | $1.32 | - | $1.12 | $1.22 | $1.45 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.70B | $4.62B | $1.53B | $2.96B | $1.99B | $2.08B | $2.63B | $2.37B | $7.03B | $5.86B |
| Accounts Receivable | $3.82B | $3.91B | $3.75B | $3.56B | $3.51B | $3.54B | $3.51B | $3.30B | $3.38B | $3.92B |
| Inventory | $2.61B | $2.49B | $2.67B | $2.69B | $2.53B | $2.33B | $2.68B | $2.67B | $2.65B | $2.59B |
| Accounts Payable | $1.79B | $1.84B | $1.70B | $1.73B | $1.72B | $1.75B | $1.60B | $1.65B | $1.68B | $1.77B |
| Current Assets | $13.94B | $12.76B | $9.61B | $11.00B | $9.53B | $9.50B | $10.06B | $9.61B | $14.37B | $13.94B |
| Total Assets | $83.54B | $83.46B | $79.90B | $81.62B | $79.12B | $77.54B | $80.61B | $78.56B | $83.40B | $84.49B |
| Current Liabilities | $7.46B | $6.81B | $6.32B | $6.79B | $6.64B | $6.80B | $7.34B | $6.70B | $7.78B | $8.27B |
| Long-term Debt | $17.56B | $18.42B | $16.83B | $16.85B | $15.98B | $15.50B | $16.32B | $16.31B | $16.42B | $16.71B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $52.95B | $52.53B | $51.07B | $52.33B | $50.85B | $49.54B | $51.30B | $49.90B | $53.44B | $53.49B |
| Retained Earnings | $47.64B | $46.89B | $45.92B | $45.24B | $44.91B | $44.19B | $43.30B | $42.67B | $41.96B | $41.07B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.32B | - | - | - | $1.30B | - | - | - | $1.74B | - |
| Investing Cash Flow | ($249.00M) | - | - | - | ($242.00M) | - | - | - | ($321.00M) | - |
| Financing Cash Flow | $46.00M | - | - | - | ($1.25B) | - | - | - | ($133.00M) | - |
| CapEx | $237.00M | - | - | - | $245.00M | - | - | - | $291.00M | - |
| Free Cash Flow | $1.08B | - | - | - | $1.05B | - | - | - | $1.45B | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 60.3% | - | 58.2% | 59.3% | 61.2% | - | 58.7% | 59.7% | 60.2% | - |
| Operating margin | 22.6% | - | 19.1% | 12.8% | 22.2% | - | 16.5% | 20.3% | 22.6% | - |
| EBITDA margin | 25.8% | - | 22.0% | 15.8% | 25.3% | - | - | - | 25.7% | - |
| Net margin | 17.3% | - | 15.0% | 9.3% | 16.6% | - | 14.1% | 15.8% | 18.8% | - |
| Free cash flow margin | 18.2% | - | - | - | 18.4% | - | - | - | 25.0% | - |
| FCF / Net income | 1.05 | - | - | - | 1.10 | - | - | - | 1.33 | - |
| R&D / Revenue | 6.5% | - | 6.2% | 6.8% | 6.6% | - | 6.6% | 6.8% | 6.3% | - |
| SG&A / Revenue | 31.3% | - | 32.9% | 39.8% | 32.4% | - | 35.5% | 32.5% | 31.2% | - |
| Effective tax rate | 16.7% | - | 15.6% | 15.3% | 15.5% | - | 16.3% | 16.3% | 14.4% | - |
| Return on assets | 1.2% | - | 1.1% | 0.7% | 1.2% | - | 1.0% | 1.2% | 1.3% | - |
| Return on equity | 1.9% | - | 1.8% | 1.1% | 1.9% | - | 1.6% | 1.8% | 2.0% | - |
| Return on invested capital | 1.6% | - | 1.4% | 0.9% | 1.6% | - | 1.2% | 1.5% | 1.6% | - |
| Liquidity | ||||||||||
| Current ratio | 1.87 | 1.87 | 1.52 | 1.62 | 1.43 | 1.40 | 1.37 | 1.43 | 1.85 | 1.68 |
| Quick ratio | 1.52 | 1.51 | 1.10 | 1.22 | 1.05 | 1.05 | 1.01 | 1.04 | 1.51 | 1.37 |
| Cash ratio | 0.76 | 0.68 | 0.24 | 0.44 | 0.30 | 0.31 | 0.36 | 0.35 | 0.90 | 0.71 |
| Leverage | ||||||||||
| Debt / Equity | 0.33 | 0.35 | 0.33 | 0.32 | 0.31 | 0.31 | 0.32 | 0.33 | 0.31 | 0.31 |
| Debt / Assets | 0.21 | 0.22 | 0.21 | 0.21 | 0.20 | 0.20 | 0.20 | 0.21 | 0.20 | 0.20 |
| Debt / EBITDA | 11.43 | - | 12.65 | 17.97 | 10.98 | - | - | - | 11.01 | - |
| Interest coverage | 21.3x | - | 17.2x | 10.7x | 19.6x | - | 11.0x | 18.0x | 20.2x | - |
| Equity multiplier | 1.58 | 1.59 | 1.56 | 1.56 | 1.56 | 1.57 | 1.57 | 1.57 | 1.56 | 1.58 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.07 | - | 0.08 | 0.07 | 0.07 | - | 0.07 | 0.07 | 0.07 | - |
| Inventory turnover | 0.90 | - | 0.95 | 0.90 | 0.88 | - | 0.90 | 0.87 | 0.87 | - |
| Days sales outstanding | 234d | - | 226d | 219d | 223d | - | 221d | 210d | 213d | - |
| Days inventory outstanding | 403d | - | 386d | 407d | 414d | - | 408d | 421d | 418d | - |
| Days payable outstanding | 277d | - | 245d | 261d | 282d | - | 243d | 259d | 265d | - |
| Cash conversion cycle | 361d | - | 367d | 365d | 355d | - | 386d | 371d | 365d | - |
| Valuation | ||||||||||
| P / E | 125.2x | - | 145.5x | 258.2x | 155.9x | - | 245.9x | 204.8x | 172.2x | - |
| P / B | 2.4x | - | 2.6x | 2.7x | 2.9x | - | 3.9x | 3.7x | 3.5x | - |
| P / S | 21.7x | - | 21.8x | 24.1x | 25.8x | - | 34.7x | 32.3x | 32.3x | - |
| EV / EBITDA | 91.7x | - | 110.6x | 167.2x | 111.6x | - | - | - | 131.7x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 3.7% | - | 4.4% | 3.4% | -0.9% | - | -15.6% | -19.8% | -19.1% | - |
| Revenue CAGR (3y) | -6.0% | - | -7.6% | -8.5% | -9.3% | - | -7.1% | -7.3% | -5.5% | - |
| Revenue CAGR (5y) | -2.8% | - | 0.6% | 2.3% | 5.7% | - | 2.9% | 2.2% | 3.5% | - |
| Gross profit growth (YoY) | 2.3% | - | 3.6% | 2.8% | 0.7% | - | -15.0% | -15.2% | -20.2% | - |
| Operating income growth (YoY) | 5.5% | - | 20.5% | -34.9% | -2.9% | - | -33.4% | -18.3% | -26.9% | - |
| Net income growth (YoY) | 7.9% | - | 11.0% | -38.8% | -12.3% | - | -27.5% | -18.0% | -25.0% | - |
| EPS growth (YoY) | 9.8% | - | 13.4% | -36.9% | -9.0% | - | -25.8% | -18.1% | -25.3% | - |
| EPS CAGR (3y) | -9.2% | - | -15.4% | -30.1% | -17.0% | - | -10.1% | -20.2% | -14.1% | - |
| EPS CAGR (5y) | -8.7% | - | 1.8% | -9.1% | 10.3% | - | 4.7% | 4.7% | 25.8% | - |
| FCF growth (YoY) | 2.9% | - | - | - | -27.2% | - | - | - | -13.4% | - |
| FCF CAGR (5y) | -7.7% | - | - | - | 9.0% | - | - | - | 21.5% | - |
| Book value growth (YoY) | 4.1% | 6.0% | -0.4% | 4.9% | -4.9% | -7.4% | -2.1% | -3.5% | 3.8% | 6.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$24.57B totalDiagnostics Segment$9.94B · 40.5%
Life Sciences Segment$7.33B · 29.9%
Biotechnology Segment$7.29B · 29.7%
Product / service
$7.29B totalRevenuefrom Contractwith Customer Measurement Recurring$6.42B · 88.1%
Revenuefrom Contractwith Customer Measurement Nonrecurring$869.00M · 11.9%
Geographic
$31.86B totalAll Other Countries$11.96B · 37.5%
US$9.98B · 31.3%
CN$2.63B · 8.3%
Western Europe$2.56B · 8.0%
North America$2.42B · 7.6%
High Growth Markets$1.98B · 6.2%
Other Developed Markets$341.00M · 1.1%
Peer comparison
Same SIC group: Industrial Instruments For Measurement, Display, and Control
Comparing DANAHER CORP /DE/ against the 5 most active filers in the same SIC group.
Dividends
$1.36/share trailing 12 months · +20.4% YoY
| Ex-date | Per share |
|---|---|
| Mar 27, 2026 | $0.4000 |
| Dec 26, 2025 | $0.3200 |
| Sep 26, 2025 | $0.3200 |
| Jun 27, 2025 | $0.3200 |
| Mar 28, 2025 | $0.3200 |
| Dec 27, 2024 | $0.2700 |
| Sep 27, 2024 | $0.2700 |
| Jun 28, 2024 | $0.2700 |
| Mar 27, 2024 | $0.2700 |
| Dec 28, 2023 | $0.2400 |
| Oct 11, 2023 | $0.2700 |
| Jun 29, 2023 | $0.2394 |
| Mar 30, 2023 | $0.2394 |
| Dec 29, 2022 | $0.2216 |
| Sep 29, 2022 | $0.2216 |
| Jun 23, 2022 | $0.2216 |
| Mar 24, 2022 | $0.2216 |
| Dec 29, 2021 | $0.1862 |
| Sep 29, 2021 | $0.1862 |
| Jun 24, 2021 | $0.1862 |
| Mar 25, 2021 | $0.1862 |
| Dec 24, 2020 | $0.1596 |
| Sep 25, 2020 | $0.1596 |
| Jun 25, 2020 | $0.1596 |